Everyday Science

ProDERM study results of Octagam® 10% treatment in patients with dermatomyositis published in the New England Journal of Medicine

Continue reading "ProDERM study results of Octagam® 10% treatment in patients with dermatomyositis published in the New England Journal of Medicine"